Neuroscience

Trial demonstrated the safety and efficacy of 100 mg of KCL-286 in participants, with no severe side effects

A multicenter study in China investigates a new set of biomarkers to screen and detect AD

Trial showed that mRNA-led CAR-T therapy may be a safe and durable treatment option for this rare disease

Findings point to the potential for using existing cancer therapies to treat drug-resistant epilepsy

Surgically disconnecting specific networks in the brain may help patients live epilepsy-free for a longer time

MS and PML experts argue that preventive screening should become the new standard of care

Transplant replaces dopaminergic neurons, which are degenerated in patients with Parkinson’s disease

Next-gen technologies and molecular tools are driving the discovery of new protein-, DNA-, and RNA-based biomarkers for rare neurological disease

Since NAD+ gets depleted with age, supplementing it via diet could decelerate neurodegeneration

Angiogenic biomarkers could allow clinicians to distinguish Alzheimer's-predominant dementia from significant vascular contribution